pferde spiegel, Table of Contents pferde spiegel 2023; 26(04): 181-188DOI: 10.1055/a-1791-6387 Fallbericht Der klinische Fall: Differenzialdiagnosen von Angesichtsschwellungen beim Pferd Dorothée Geiersberger , Bernadette Rohwerder Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Dixon P. Swellings of the head region in the horse. In Practice 1991; 13: 257-263 2 Witte TH. Disease of the Nasal Cavity and Paranasal Sinuses. In: Sprayberry KA, Robinson NE. Hrsg. Robinsonʼs Current Therapy in Equine Medicine. St. Louis: WB. Saunders; 2015: 213-220 3 Carlson N, Eastman T, Winfield L. Sialolithiasis in horses: A retrospective study of 25 cases (2002–2013). Can Vet J 2015; 56: 1239-1244 4 Dawson C, Dixon J, Lam R. et al. Differential diagnoses, investigation and management of periocular swelling close to the nasolacrimal duct in horses – A case report of Dacryops. Vet Ophthalmol 2016; 19: 427-431 5 McGowan TW, Pinchbeck GP, McGowan CM. Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses. Equine Vet J 2012; 1-6 6 Cotchin E. A general survey of tumours in the horse. Equine Vet J 1977; 9: 16-21 7 Knickelbein KE, Holmberg BJ, Lassaline ME. Equine retrobulbar disease: Diagnoses and outcomes of 15 horses with exophthalmos (1988–2017). Equine Vet Educ 2019; 31: 601-608 8 Wollanke B, Gerhards H, Cronau M. Diagnostik und Therapie periorbitaler Erkrankungen von Pferden: Wann ist eine Computertomographie (CT) oder Magnetresonanztomographie (MRT) indiziert?. Pferdeheilk 2006; 22: 431-438 9 Taintor JS. Lymphoma. In Sprayberry KA, Robinson NE, Hrsg. Robinsonʼs Current Therapy in Equine Medicine. St. Louis: W.B. Saunders; 2015: 409-414 10 Fey K. Hämatopoetisches System. In Dietz O, Huskamp B, Hrsg. Handbuch Pferdepraxis. Stuttgart: Thieme; 2006: 273-295 11 Watson J. Diseases of the Hematopoietic and Hemolymphatic Systems. In Smith B, Hrsg. Large Animal Internal Medicine. St. Louis: Elsevier; 2015: 1044-1083 12 Larsdotter S, Nostell K, von Euler H. Serum thymidine kinase activity in clinically healthy and diseased horses: A potential marker for lymphoma. Vet J 2015; 205 (02) 313-316 13 Wang L, Unger L, Sharif H. et al. Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma. BMC Molecular Cell Biol 2021; 22 (59) 1-12 14 Moore C, Stefanovski D, Luethy D. Clinical performance of a commercially available thymidine kinase 1 assay for diagnosis of lymphoma in 42 hospitalized horses (2017–2020). J Vet Intern Med 2021; 35: 2495-2499 15 Tothova C, Nagy O, Kovac G. Serum proteins and their diagnostic utility in veterinary medicine: a review. Veterinarni Medicina 2016; 61 (09) 475-496 16 Winter J, Kershaw O, Schmitz R. et al. Das equine leukämische Lymphom – eine seltene Unterart des equinen Lymphoms. Tierärztl Prax 2014; 42 (G): 311-317 17 Durham A, Pillitteri C, San Myint M. et al. Two hundred three cases of equine lymphoma classified according to the World Health Organization (WHO) classification criteria. Vet Pathol 2013; 50 (01) 86-93 18 Hollis AR. PCR for antigen receptor rearrangement (PARR) in equine veterinary medicine. Equine Vet Educ 2019; 31: 419-420 19 Luethy D, Frimberger AE, Bedenice D. et al. Retrospective evaluation of clinical outcome after chemotherapy for lymphoma in 15 equids (1991–2017). J Vet Intern Med 2019; 1-8 20 Brunner J, Kuntz J. Strahlentherapie in der Pferdemedizin – die Zukunft hat bereits begonnen. Prakt Tierarzt 2019; 1050-1064
